Benign Prostate Disease and
Benign Prostatic Enlargement (or BPH), is a common age-related benign condition which effects men, to some degree, from age 40. It is commonly associated with worsening urinary symptoms, including altered urinary flow, and altered bladder capacity.
There are many aspects to the evaluation and management of this condition. This includes evaluation of lifestyle factors, the prostate itself, and the remainder of the urinary tract. This can also include assessment to exclude prostate cancer.
If there is concern regarding the effects of the condition, management strategies include medication, together with multiple options for procedural intervention. This is an area evolving rapidly with multiple technologies under evaluation. Comprehensive assessment of the condition is important to determine the most appropriate intervention for an individual’s situation.
This is an area Roger Watson has had extensive involvement in over many years and he continues to be involved in the evaluation and use of the latest technological developments.